Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-047725

Chief Financial Officer sold 4,864 shares at $2.84 ($13,814)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-27 Sale : show line 1 in the form 10b5-1 −298 $2.84 $846 379,133 D
2025-03-27 Sale : show line 2 in the form 10b5-1 −4,566 $2.84 $12,967 374,567 D
Open-market sales · 4,864 sh · avg $2.84 · $13,814
Loading xslF345X05/ownership.xml…